RAFFA WEALTH MANAGEMENT, LLC’s 10x Genomics TXG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-31
Closed -$5.21K 1124
2021
Q1
$5.21K Hold
31
﹤0.01% 396
2020
Q4
$4.39K Sell
31
-14
-31% -$2.03K ﹤0.01% 390
2020
Q3
$5.61K Sell
45
-11
-20% -$1.16K ﹤0.01% 310
2020
Q2
$5K Buy
56
+24
+75% +$1.87K ﹤0.01% 317
2020
Q1
$1.99K Buy
+32
New +$2.5K ﹤0.01% 430

Other funds holding TXG

RAFFA WEALTH MANAGEMENT, LLC's TXG Position: Q2 2021 in Review

RAFFA WEALTH MANAGEMENT, LLC sold out of 10x Genomics (TXG) in Q2 2021, closing a stake of 31 shares — an estimated $5.21K sold.

RAFFA WEALTH MANAGEMENT, LLC first reported a position in TXG in Q1 2020 and held it in 5 quarters. The position peaked at $5.61K in Q3 2020. 340 funds tracked by Wall St. Rank hold TXG as of Q2 2021.

  • RAFFA WEALTH MANAGEMENT, LLC reported no remaining 10x Genomics position as of Q2 2021 after selling out during the quarter.
  • RAFFA WEALTH MANAGEMENT, LLC sold 31 10x Genomics shares in Q2 2021, an estimated $5.21K.
  • RAFFA WEALTH MANAGEMENT, LLC first reported a position in 10x Genomics in Q1 2020 and held it in 5 quarters.
  • RAFFA WEALTH MANAGEMENT, LLC's 10x Genomics position peaked at $5.61K in Q3 2020.
  • 340 funds tracked by Wall St. Rank held 10x Genomics as of Q2 2021.

Based on RAFFA WEALTH MANAGEMENT, LLC's 13F filing for Q2 2021, filed 27 Jul 2026.